COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,248 Articles (22,733 medRxiv, 8,515 bioRxiv)

Most recent first Previous |  Page 2602: Articles 26011-26020  | Next

Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry
Ozono, S., Zhang, Y., Ode, H., Seng, T. T., Imai, K., Miyoshi, K., Kishigami, S., Ueno, T., Iwatani, Y., Suzuki, T., Tokunaga, K.
10.1101/2020.06.15.151779 — Posted: 2020-06-15
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera
Pape, C., Remme, R., Wolny, A., Olberg, S., Wolf, S., Cerrone, L., Cortese, M., Klaus, S., Lucic, B., Ullrich, S., Anders-Össwein, M., Wolf, S., Berati, C., Neufeld, C., Ganter, M., Schnitzler, P., Merle, U., Lusic, M., Boulant, S., Stanifer, M., Bartenschlager, R., Hamprecht, F. A., Kreshuk, A., Tischer, C., Kräusslich, H.-G., Müller, B., Laketa, V.
10.1101/2020.06.15.152587 — Posted: 2020-06-15 Discussion: Onsite
Genome-wide mapping of therapeutically-relevant SARS-CoV-2 RNA structures
Manfredonia, I., Nithin, C., Ponce-Salvatierra, A., Ghosh, P., Wirecki, T. K., Marinus, T., Ogando, N. S., Snijder, E. J., van Hemert, M. J., Bujnicki, J. M., Incarnato, D.
10.1101/2020.06.15.151647 — Posted: 2020-06-15
The SARSCoV2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier
Buzhdygan, T. P., DeOre, B. J., Baldwin-Leclair, A., McGary, H., Razmpour, R., Galie, P. A., Potula, R., Andrews, A. M., Ramirez, S. H.
10.1101/2020.06.15.150912 — Posted: 2020-06-15 Discussion: Onsite
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis
Herrera, N. G., Morano, N. C., Celikgil, A., Georgiev, G. I., Malonis, R. J., Lee, J. H., Tong, K., Vergnolle, O., Massimi, A. B., Yen, L. Y., Noble, A. J., Kopylov, M., Bonanno, J. B., Garrett-Thompson, S. C., Hayes, D. B., Brenowitz, M., Garforth, S. J., Eng, E. T., Lai, J. R., Almo, S. C.
10.1101/2020.06.14.150607 — Posted: 2020-06-15 Discussion: Offsite
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection
Conzelmann, C., Gilg, A., Gross, R., Schuetz, D., Preising, N., Staendker, L., Jahrsdoerfer, B., Schrezenmeier, H., Sparrer, K. M., Stamminger, T., Stenger, S., Muench, J., Mueller, J. A.
10.1101/2020.06.14.150862 — Posted: 2020-06-15
A novel biparatopic antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
Miao, X., Luo, Y., Huang, X., Lee, S. M. Y., Yuan, Z., Tang, Y., Chen, L., Wang, C., Jiang, W., Gao, W., Song, X., Yan, Y., Pang, T., Zou, Y., Fu, W., Wan, L., Jramillo, J. G., Knight, M., Tan, T. K., Rijal, P., Townsend, A., Sun, J., Liu, X., James, W. S., Tsun, A., Xu, Y.
10.1101/2020.06.14.147868 — Posted: 2020-06-15
Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution
Overholt, K. J., Krog, J. R., Bryson, B. D.
10.1101/2020.06.15.147470 — Posted: 2020-06-15 Discussion: Onsite
Novel ACE2-IgG1 fusions with increased activity against SARS-CoV-2
Iwanaga, N., Cooper, L., Rong, L., Beddingfield, B., Crabtree, J., Tripp, R. A., Kolls, J.
10.1101/2020.06.15.152157 — Posted: 2020-06-15 Discussion: Onsite
Increased plasma heparanase activity in COVID-19 patients
Buijsers, B., Yanginlar, C., Grondman, I., de Nooijer, A., Maciej-Hulme, M. L., Jonkman, I., Janssen, N., Rother, N., de Graaf, M., Pickkers, P., Kox, M., Joosten, L., Nijenhuis, T., Netea, M. G., Hillbrands, L., van de Veerdonk, F., Duivenvoorden, R., de Mast, Q., van der Vlag, J.
10.1101/2020.06.12.20129304 — Posted: 2020-06-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).